Cresset Asset Management’s Exact Sciences EXAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $828K | Buy |
15,578
+6,862
| +79% | +$365K | ﹤0.01% | 837 |
|
|
2025
Q1 | $377K | Sell |
8,716
-18
| -0.2% | -$779 | ﹤0.01% | 1194 |
|
|
2024
Q4 | $491K | Sell |
8,734
-2,218
| -20% | -$125K | ﹤0.01% | 1075 |
|
|
2024
Q3 | $746K | Sell |
10,952
-2,097
| -16% | -$143K | ﹤0.01% | 1287 |
|
|
2024
Q2 | $551K | Buy |
13,049
+1,286
| +11% | +$54.3K | ﹤0.01% | 1358 |
|
|
2024
Q1 | $812K | Sell |
11,763
-1,670
| -12% | -$115K | ﹤0.01% | 1068 |
|
|
2023
Q4 | $994K | Buy |
13,433
+59
| +0.4% | +$4.37K | 0.01% | 877 |
|
|
2023
Q3 | $912K | Sell |
13,374
-2,613
| -16% | -$178K | ﹤0.01% | 868 |
|
|
2023
Q2 | $1.5M | Buy |
15,987
+12,725
| +390% | +$1.19M | ﹤0.01% | 628 |
|
|
2023
Q1 | $221K | Buy |
+3,262
| New | +$221K | ﹤0.01% | 721 |
|
|
2022
Q3 | – | Sell |
-5,340
| Closed | -$207K | – | 906 |
|
|
2022
Q2 | $207K | Sell |
5,340
-30
| -0.6% | -$1.16K | ﹤0.01% | 831 |
|
|
2022
Q1 | $375K | Sell |
5,370
-2,762
| -34% | -$193K | ﹤0.01% | 697 |
|
|
2021
Q4 | $633K | Sell |
8,132
-12,693
| -61% | -$988K | 0.01% | 617 |
|
|
2021
Q3 | $1.99M | Buy |
20,825
+4,961
| +31% | +$473K | 0.03% | 236 |
|
|
2021
Q2 | $1.97M | Buy |
15,864
+2,801
| +21% | +$348K | 0.03% | 208 |
|
|
2021
Q1 | $1.72M | Buy |
13,063
+6,862
| +111% | +$905K | 0.03% | 192 |
|
|
2020
Q4 | $822K | Buy |
+6,201
| New | +$822K | 0.01% | 282 |
|
|
2019
Q2 | – | Sell |
-558
| Closed | -$48K | – | 855 |
|
|
2019
Q1 | $48K | Buy |
558
+321
| +135% | +$27.6K | ﹤0.01% | 795 |
|
|
2018
Q4 | $15K | Buy |
+237
| New | +$15K | ﹤0.01% | 768 |
|